Catalysts, reliability, and smart-money flow — every figure traced to a primary source. No predictions. No advice.
Free preview · Pro · $9/mo
Built for the retail investor who refuses to be downstream.
Twelve months of forward visibility across 30+ names. When a date slips, the diff is surfaced — never silently updated.
Per-ticker accuracy scoring against historical guidance, with sector base rates for context. The disclosure track record, quantified.
Insider trades, congressional positions, KOL payments, ETF flow, lobbying spend — surfaced inside every company view.
SEC filings, ClinicalTrials.gov edits, FDA notices, IR releases — verbatim quotes you can audit. Plain English by default.
Where every figure comes from, how we handle uncertainty, and what we refuse to do.
Catalysts are announced at varying precision. A PDUFA gets a hard date; corporate guidance might only narrow to a quarter; analyst expectation might be just “later this year.” We surface the actual precision the source provided — never invent specificity that isn’t there.
A press release might say Q2 while an 8-K says June 18. When that happens, we don’t pick silently. The disclosure timeline shows both quotes side-by-side with their dates and source pills — you decide what to trust.
Most catalyst trackers are a layer of opinion sitting on top of public data. We’re a transparent surface. Here’s the discipline:
Found a date that doesn’t match the source? A quote we got wrong? An obvious public dataset we should be ingesting? Tell us. Corrections post publicly.
Cancel anytime · no questions asked
Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.